insights_auto
Why is CLLS down 4.49%?
Dive Deeperchevron_right
CLLS:NASDAQ
Cellectis SA
$0.98
arrow_downward
-4.49%(-0.046) 1D
Nov 19, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CLLS...
Open
$1.01
High
$1.08
Low
$0.95
Mkt. cap
74.73M
Avg. vol.
92.61K
Volume
65.44K
52-wk high
$5.45
52-wk low
$0.88
EPS
-$1.27
Beta
3.21
Shares outstanding
100.73M
No. of employees
227
Open
$1.01
High
$1.08
Low
$0.95
Mkt. cap
74.73M
Avg. vol.
92.61K
Volume
65.44K
52-wk high
$5.45
52-wk low
$0.88
EPS
-$1.27
Beta
3.21
Shares outstanding
100.73M
No. of employees
227
News stories
From web sources and news partners
Idéal Investisseur
·
2 days ago
Cellectis shares fall 64.5% over the quarter and remain below their MM20
Profile
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina. Wikipedia
About Cellectis SA
CEOAndré Choulika
Employees227
Founded1999
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitecellectis.com